A detailed history of Sutton Place Investors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sutton Place Investors LLC holds 7,643 shares of BMY stock, worth $429,689. This represents 0.25% of its overall portfolio holdings.

Number of Shares
7,643
Previous 7,326 4.33%
Holding current value
$429,689
Previous $304,000 29.93%
% of portfolio
0.25%
Previous 0.21%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$39.66 - $51.75 $12,572 - $16,404
317 Added 4.33%
7,643 $395,000
Q2 2024

Jul 18, 2024

SELL
$40.25 - $52.99 $551,425 - $725,963
-13,700 Reduced 65.16%
7,326 $304,000
Q1 2024

Apr 22, 2024

BUY
$47.98 - $54.4 $307,167 - $348,268
6,402 Added 43.78%
21,026 $1.14 Million
Q4 2023

Jan 29, 2024

BUY
$48.48 - $57.85 $708,971 - $845,998
14,624 New
14,624 $750,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sutton Place Investors LLC Portfolio

Follow Sutton Place Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sutton Place Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sutton Place Investors LLC with notifications on news.